Long-Term Outcomes of Early Coronary Artery Disease Testing After New-Onset Heart Failure.

Early CAD testing after incident HF was associated with a modest mortality benefit, driven mostly by subsequent statin therapy. Further investigation on clinician barriers to testing and treating high-risk patients may improve adherence to guideline-recommended cardiovascular interventions.